Case Conversation: Initial von Willebrand factor antigen values in adolescent females predict future values

June 12, 2024

Register Here

The FWGBD Case Conversation series will feature leading experts in the areas of hematology and reproductive health discussing challenging cases, sharing insights, and reviewing recent journal articles regarding the diagnosis, treatment, and management of blood disorders affecting women and girls across the lifespan. All registrants will receive a copy of the selected journal article in advance.

In our next Case Conversation program on Wednesday, June 12, 2024, from 12:00-1:00 p.m. ET (11:00 a.m. – 12:00 p.m. CT, 10:00 – 11:00 a.m. MT, 9:00-10:00 a.m. PT), Drs. Clay Cohen, Mark Zobeck, and Jackie Powers will share their article, Initial von Willebrand factor antigen values in adolescent females predict future values. Following the presentation, there will be a short Q&A with attendees.

During this conversation, the authors will share the development of a von Willebrand Factor (VWF) prediction model for adolescent females based on initial VWF results.

This case conversation will address the following learning objectives:

  1. Discuss the development of a predictive model for diagnosis of von Willebrand Disease in adolescent females.
  2. Compare the differences in patient outcomes when intake is performed at outpatient clinics versus acute care.
  3. Interpret the findings of the predictive model for von Willebrand Factor to ultimately and accurately diagnose von Willebrand Disease.

Clay T. Cohen, MD
Director, Young Women’s Bleeding Disorders Clinic
Assistant Professor, Department of Pediatrics,
Section of Hematology/Oncology
Baylor College of Medicine

Jacquelyn M. Powers, MD, MS
Director, Iron Disorders and Nutritional Anemias Program
Section Chief, Pediatric Hematology
Baylor College of Medicine

Mark C. Zobeck, MD, MPH
Assistant Professor, Department of Pediatrics
Section of Hematology-Oncology
Baylor College of Medicine

In support of improving patient care, this activity has been planned and implemented by CineMed and the Foundation for Women & Girls with Blood Disorders. CineMed is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CineMed designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity provides 1 contact hour for nurses.  

Other Healthcare Professionals
All other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for activities designated for AMA PRA Category 1 Credits™, consult your professional licensing board.